Search for: "Anda Inc."
Results 201 - 220
of 962
Sorted by Relevance
|
Sort by Date
23 Feb 2011, 10:58 am
USA, Inc., 557 F.3d 1346 (Fed. [read post]
14 Sep 2014, 9:59 pm
Millennium Pharmaceuticals Inc. v. [read post]
9 Sep 2013, 9:27 pm
• Defendant: Akorn, Inc. [read post]
20 Mar 2016, 9:06 pm
Vanda Pharmaceuticals Inc. v. [read post]
31 Aug 2014, 9:05 pm
Watson Laboratories Inc. et al. 1:14-cv-01051; filed August 15, 2014 in the District Court of Delaware • Plaintiff: AstraZeneca AB • Defendants: Watson Laboratories Inc.; Actavis Inc.; Actavis LLC Infringement of U.S. [read post]
1 Mar 2015, 9:59 pm
Par Pharmaceutical, Inc. et al. 1:15-cv-01454; filed February 25, 2015 in the District Court of Massachusetts • Plaintiff: Shire LLC • Defendants: Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
29 Jun 2014, 9:21 pm
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
4 Sep 2016, 9:13 pm
Horizon Therapeutics, Inc. v. [read post]
22 Apr 2014, 11:29 pm
”Power-One, Inc. v. [read post]
2 Aug 2010, 8:05 am
In the ANDA case Sepracor Inc. v. [read post]
3 Apr 2012, 9:15 am
Watson Laboratories, Inc. [read post]
6 Sep 2010, 9:48 pm
Teva Pharmaceuticals USA, Inc. [read post]
22 Dec 2017, 10:00 am
Sleet in Amgen Inc. v. [read post]
22 Jul 2015, 12:40 pm
It has also won a lawsuit, which was heard by the Federal Circuit, against Mylan Pharmaceuticals Inc. for infringing the patented Strattera®. [read post]
9 Jun 2011, 10:16 am
According to Alcon, Watson's April 27 letter and ANDA stated that Alcon's patents are invalid, unenforceable and/or will not be infringed. [read post]
6 Nov 2020, 7:16 am
Mylan Pharm., Inc., 173 F.3d 829 (Fed. [read post]
16 Mar 2009, 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. [read post]
27 Aug 2014, 1:35 am
As to infringement, the filing of an ANDA alone does not mean thata produced product infringes.The [ANDA] filing only constituted a technical act of infringement for jurisdictional purposes. [read post]
12 Nov 2015, 9:59 pm
The case involved ANDA litigation over alosetron, marketed by Prometheus as Lotronex®; this drug is used for treating irritable bowel syndrome (IBS). [read post]
3 Jun 2010, 9:36 pm
Celgene initiated the dispute in January 2007, after Barr filed an ANDA for generic thalidomide in September 2006 (see "Court Report," February 28, 2007). [read post]
